Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
157.24
+9.47 (6.41%)
At close: Jul 17, 2026, 4:00 PM EDT
159.16
+1.92 (1.22%)
After-hours: Jul 17, 2026, 7:52 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.26 billion as of July 17, 2026. Its market cap has increased by 617.78% in one year.
Market Cap
2.26B
Enterprise Value
2.01B
1-Year Change
617.78%
Ranking
Category
Stock Price
$157.24
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.26B, an increase of 1,466.49%. That is a compound annual growth rate of 468.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.26B | 82.03% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.40B |
| Mineralys Therapeutics | 2.39B |
| Vericel | 2.38B |
| Agios Pharmaceuticals | 2.36B |
| Biohaven | 2.32B |
| Nektar Therapeutics | 2.31B |
| Hemab Therapeutics Holdings | 2.30B |
| Zai Lab | 2.27B |